PCM Encore LLC Makes New Investment in Ventas, Inc. $VTR

PCM Encore LLC purchased a new position in Ventas, Inc. (NYSE:VTR) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 5,425 shares of the real estate investment trust’s stock, valued at approximately $482,000.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Dynamic Wealth Strategies LLC bought a new stake in shares of Ventas during the 1st quarter worth $25,000. Wiser Advisor Group LLC bought a new position in Ventas in the third quarter valued at $27,000. Meeder Asset Management Inc. bought a new position in Ventas in the second quarter valued at $30,000. IFC & Insurance Marketing Inc. bought a new position in Ventas in the fourth quarter valued at $30,000. Finally, Elyxium Wealth LLC purchased a new stake in Ventas during the fourth quarter valued at about $33,000. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Ventas Price Performance

Shares of NYSE:VTR opened at $92.82 on Friday. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86. The stock has a market cap of $47.61 billion, a PE ratio of 171.89, a PEG ratio of 2.12 and a beta of 0.69. The company’s fifty day moving average is $91.18 and its 200 day moving average is $87.04. Ventas, Inc. has a 52 week low of $66.38 and a 52 week high of $101.60.

Ventas (NYSE:VTR) last posted its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.01. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The business had revenue of $1.73 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same period in the prior year, the business posted $0.87 earnings per share. The company’s revenue was up 21.7% on a year-over-year basis. Research analysts anticipate that Ventas, Inc. will post 3.89 earnings per share for the current year.

Insider Buying and Selling at Ventas

In related news, Director Michael J. Embler bought 2,500 shares of the company’s stock in a transaction that occurred on Wednesday, June 3rd. The stock was bought at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the acquisition, the director directly owned 19,202 shares of the company’s stock, valued at $1,513,309.62. The trade was a 14.97% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.53% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on VTR shares. Citigroup lifted their price target on Ventas from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Tuesday, August 4th. JPMorgan Chase & Co. increased their price objective on Ventas from $93.00 to $94.00 and gave the company an “overweight” rating in a research report on Monday, May 11th. KeyCorp raised their price objective on Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $100.00 target price on shares of Ventas in a research report on Tuesday, June 16th. Finally, Jefferies Financial Group upped their target price on Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, May 12th. Fifteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $98.00.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.